TEL. 03-3353-8111
〒162-8666 8-1, Kawada-cho, Shinjuku-ku, Tokyo
In 1979, Kidney center was established in Tokyo women’s medical university,
          and the department of medicine (nephrology) was also established as a clinical
          department in that Kidney Center at that time.
          In 1983, the department medicine IV was established as the chair. Under
          the guidance of professor Junichi Hoshino, about 90 doctors of the member
          of department of medicine IV make an effort on the clinical site, research,
          and education every day. 
          Our clinical policy is to give the first priority to our patients. Chronic
          kidney disease is not short term disease, then we must help and cooperate
          our CKD patients for a long time. Without considering a disease alone,
          we always take care of our CKD patients with considering patient’s minds
          and social backgrounds. That’s our most important point. Therefore, we
          have considered that our aim of research is to analyze the questions from
          patients in actual clinical settings and to return the answers and results
          to the patients. The senior residents make an effort on clinical and/or
          basic research, because we recognize that to take Ph.D. (Doctor of Philosophy)
          is the start to become a real doctor. We perform the clinical research
          based on a lot of clinical and pathological data, and also perform the
          basic research with animal disease models, patient’s genetic information,
          and regenerative medicine to recognize deeply the pathophysiology. 
① Chronic Glomerulonephritis (CGN): Rituximab treatment for nephrotic syndrome
          (NS). Prognosis, treatment, and risk factors of IgA nephropathy, lupus
          nephritis and ANCA related nephritis. 
          ② Chronic Kidney Disease (CKD): Analysis of diabetic nephropathy, mineral
          and bone disorder (MBD), vascular calcification (VC)and risk factors, renal
          rehabilitation in CKD patients. 
          ③ Autosomal dominant polycystic kidney disease (ADPKD): Genetic analysis.
          Tolvaptan treatment. Quality of life in ADPKD patients with polycystic
          liver.
          ④ Hemodialysis (HD): Analysis of mineral and bone disorder, vascular calcification,
          renal rehabilitation, anemia, and frailty/sarcopenia in HD patients
Professor and Chairman Junichi HOSHINO 
          Visiting Professor Ken TSUCHIYA
          Visiting Professor Kousaku NITTA 
          Visiting Professor Sachiko WAKAI 
          Visiting Professor Keiko UCHIDA 
          Lecturer Hiroshi KATAOKA 
          Lecturer Shun MANABE 
          Lecturer Kohei UNAGAMI 
Research Achievements Database
〒162-8666
        8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL +81-3-3353-8111